http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-110526916-B
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D487-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D487-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-53 |
| filingDate | 2019-05-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2021-07-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2021-07-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CN-110526916-B |
| titleOfInvention | Deuterated Capmatinib compound and application thereof |
| abstract | The invention discloses a deuterated Capmatinib compound and application thereof, and particularly discloses a compound shown as a formula (I) or an optical isomer, a pharmaceutically acceptable salt, a hydrate or a solvate thereof, wherein R is 1 ‑R 16 Each independently selected from H, D, and not all H. The compounds and salts, hydrates or solvates thereof provided by the invention have anticancer activity, better metabolic stability and pharmacokinetic properties and good application prospect. |
| priorityDate | 2018-05-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 71.